1. Home
  2. ARDX vs ICFI Comparison

ARDX vs ICFI Comparison

Compare ARDX & ICFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ardelyx Inc.

ARDX

Ardelyx Inc.

HOLD

Current Price

$7.32

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo ICF International Inc.

ICFI

ICF International Inc.

HOLD

Current Price

$87.07

Market Cap

1.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARDX
ICFI
Founded
2007
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
2014
2006

Fundamental Metrics

Financial Performance
Metric
ARDX
ICFI
Price
$7.32
$87.07
Analyst Decision
Strong Buy
Buy
Analyst Count
10
4
Target Price
$12.95
$99.25
AVG Volume (30 Days)
5.9M
129.7K
Earning Date
02-19-2026
02-26-2026
Dividend Yield
N/A
0.63%
EPS Growth
N/A
N/A
EPS
N/A
5.30
Revenue
$398,234,000.00
$1,925,502,000.00
Revenue This Year
$22.44
N/A
Revenue Next Year
$34.00
$2.52
P/E Ratio
N/A
$16.66
Revenue Growth
58.12
N/A
52 Week Low
$3.21
$72.03
52 Week High
$8.40
$117.71

Technical Indicators

Market Signals
Indicator
ARDX
ICFI
Relative Strength Index (RSI) 49.07 45.22
Support Level $6.92 $87.93
Resistance Level $8.02 $94.40
Average True Range (ATR) 0.41 2.72
MACD -0.13 -0.99
Stochastic Oscillator 17.31 13.10

Price Performance

Historical Comparison
ARDX
ICFI

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About ICFI ICF International Inc.

ICF International Inc provides professional services and technology-based solutions to government and commercial clients, including management, marketing, technology, and policy consulting and implementation services. Its services support clients that operate in four key markets that include Energy, Environment, Infrastructure and Disaster Recovery; Health and Social Programs and Security and Other Civilian & Commercial. The Company's majority clients are United States federal government departments and agencies. It operates in a single segment, which is providing professional services.

Share on Social Networks: